Venetoclax plus hypomethylating agent in blast-phase myeloproliferative neoplasm: preliminary experience with 12 patients

Naseema Gangat, Erika Morsia, James M. Foran, Jeanne M. Palmer, Michelle A. Elliott, Ayalew Tefferi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
JournalBritish journal of haematology
DOIs
StateAccepted/In press - 2020

Keywords

  • blast phase MPN
  • decitabine
  • venetoclax
  • zacitidine

ASJC Scopus subject areas

  • Hematology

Cite this